Mellow a multi-brand cannabis e-commerce and marketing company owned by CBD of Denver, Inc. CBDD, signed a master distribution agreement with cDistro, the operating entity of Marijuana Company of America, Inc. MCOA
cDistro and Mellow will be distributing dosist health's complete collection of high concentration CBD+ formulas & products, specifically engineered to target the need-states of sleep, calm, and relief. The dosist health collection features three performance categories including dose drop CBD+ tinctures, a full suite of CBD+ fast-acting topical solutions, and their new rapid onset gummies that are vegan, non-GMO, and made with natural flavors.
The master distribution agreement includes the launch and distribution of dosist health's line of high concentration CBD+ formulas & products to the UK & Europe. dosist is a globally recognized, modern wellness company empowering people to naturally manage their health & happiness through dose-controlled cannabinoid therapy. dosist is best known for its targeted formulas, proprietary dose-controlled devices, rigorous testing and use of medical grade and recyclable materials.
cDistro distributes CBD brands, along with smoke and vape shop-related products to wholesalers, c-stores, specialty retailers, and consumers in North America.
Mellow group operates as a multi-brand e-commerce marketplace, a full-service digital & performance marketing agency, as well as a market expansion service into the Asian markets and was recently acquired by CBD of Denver.
"The UK & EU vape/e-cigarette markets are growing extremely quickly and according to Statista are forecast to be valued at $4.2bn and $11bn respectively by 2025. These buying trends are moving extremely quickly and as more and more brands are back-filling the space being left by the nicotine and cigarette products, consumers are responding with purchasing habits that haven't been seen in a long time," stated Paul Gurney, CEO of CBD of Denver.
Photo by Elsa Olofsson on Unsplash
Related News
Marijuana Company Of America Revenue In Q1 2022 Grows 1507% YoY, Here Is How
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!